Disruption of latent inhibition in the rat by the 5-HT2 agonist DOI: effects of MDL 100,907, clozapine, risperidone and haloperidol (Q36894780)

16 August 2017

title

Disruption of latent inhibition in the rat by the 5-HT2 agonist DOI: effects of MDL 100,907, clozapine, risperidone and haloperidol (English)

1 reference

16 August 2017

1 reference

J M Hitchcock

1

1 reference

16 August 2017

S Lister

series ordinal

2

1 reference

16 August 2017

T R Fischer

series ordinal

3

1 reference

16 August 2017

J G Wettstein

series ordinal

4

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 October 1997

1 reference

Behavioural Brain Research

16 August 2017

published in

1 reference

16 August 2017

volume

88

1 reference

16 August 2017

issue

1

1 reference

16 August 2017

page(s)

43-49

1 reference

Differential performance of acute and chronic schizophrenics in a latent inhibition task.

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2902315-2

7 January 2021

Sensorimotor gating and schizophrenia. Human and animal model studies

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2902315-2

7 January 2021

Binding of typical and atypical antipsychotics to 5-HT1C and 5-HT2 sites: clozapine potently interacts with 5-HT1C sites

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2902315-2

7 January 2021

5,7-Dihydroxytryptamine lesions in the fornix-fimbria attenuate latent inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2902315-2

7 January 2021

The effects of ritanserin, RU 24969 and 8-OH-DPAT on latent inhibition in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2902315-2

7 January 2021

Effects of antipsychotic drugs on latent inhibition: sensitivity and specificity of an animal behavioral model of clinical drug action.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2902315-2

7 January 2021

The latent inhibition model of schizophrenic attention disorder. Haloperidol and sulpiride enhance rats' ability to ignore irrelevant stimuli

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2902315-2

7 January 2021

Abolition of the acquisition but not the expression of latent inhibition by chlordiazepoxide in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2902315-2

7 January 2021

Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2902315-2

7 January 2021

The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: implications for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2902315-2

7 January 2021

Abolition of latent inhibition by a single 5 mg dose of d-amphetamine in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2902315-2

7 January 2021

Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2902315-2

7 January 2021

Nicotine blocks latent inhibition in rats: evidence for a critical role of increased functional activity of dopamine in the mesolimbic system at conditioning rather than pre-exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2902315-2

7 January 2021

Amphetamine-induced disruptions of latent inhibition are reinforcer mediated: implications for animal models of schizophrenic attentional dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2902315-2

7 January 2021

WAY100635 and latent inhibition in the rat: selective effects at preexposure

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2902315-2

7 January 2021

Differential effects of intra-accumbens and systemic amphetamine on latent inhibition using an on-baseline, within-subject conditioned suppression paradigm.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2902315-2

7 January 2021

Latent inhibition: the effect of nonreinforced pre-exposure to the conditional stimulus.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2902315-2

7 January 2021

Reversal of amphetamine-induced behaviours by MDL 100,907, a selective 5-HT2A antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2902315-2

7 January 2021

Effects of typical and atypical antipsychotic drugs on two-way active avoidance. Relationship to DA receptor blocking profile

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2902315-2

7 January 2021

The selective 5-HT2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2902315-2

7 January 2021

Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2902315-2

7 January 2021

Differential effects of lesions in medial and dorsal raphe of the rat: latent inhibition and septohippocampal serotonin levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2902315-2

7 January 2021

Disruption of latent inhibition following systemic administration of parachlorophenylalanine (PCPA)

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2902315-2

7 January 2021

Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2902315-2

7 January 2021

Latent inhibition in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2902315-2

7 January 2021

Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2902315-2

7 January 2021

Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and ondansetron: implications for a possible antipsychotic action of ondansetron.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2902315-2

7 January 2021

Facilitation of latent inhibition by haloperidol in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2902315-2

7 January 2021

The effects of the new antipsychotic, sertindole, on latent inhibition in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2902315-2

7 January 2021

Disruption of latent inhibition by acute administration of low doses of amphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2902315-2

7 January 2021

Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2902315-2

7 January 2021

The latent inhibition model of schizophrenia: further validation using the atypical neuroleptic, clozapine.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2902315-2

7 January 2021

Effects of a selective 5-HT2 agonist, DOI, on 5-HT neuronal firing in the dorsal raphe nucleus and 5-HT release and metabolism in the frontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2902315-2

7 January 2021

10.1016/S0166-4328(97)02315-2

Identifiers

DOI

1 reference

16 August 2017

1 reference